Talon Capital Corp. TLNC
10.24
0.03
0.29%
as of 25 Sep
- Market cap
- $347.4M
- P/E
- —
Follow TLNC
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | 9.87 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | — | — | 10.18 |
High Price
|
|||
| — | — | — | — | — | — | — | — | — | — | Employees | |||
| — | — | — | — | — | — | — | — | — | — | Revenue/Emp | |||
| — | — | — | — | — | — | — | — | — | — | Revenue | |||
| — | — | — | — | — | — | — | — | — | — | Gross Margin | |||
| — | — | — | — | — | — | — | — | — | 3 |
EBT
|
|||
| — | — | — | — | — | — | — | — | — | 0.00% |
EBT Margin
|
|||
| — | — | — | — | — | — | — | — | — | 3 |
Net Income
|
|||
| — | — | — | — | — | — | — | — | — | — | Depreciation | |||
| — | — | — | — | — | — | — | — | — | 0.00 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | — | — | — | 0.33 |
Earnings/Sh
|
|||
| — | — | — | — | — | — | — | — | — | (0.06) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | — | — | — | 0.00 |
Capex/Sh
|
|||
| — | — | — | — | — | — | — | — | — | (0.06) |
Free CF/Sh
|
|||
| — | — | — | — | — | — | — | — | — | (0.92) |
Book Value/Sh
|
|||
| — | — | — | — | — | — | — | — | — | 8 |
Shares
|
|||
| — | — | — | — | — | — | — | — | — | — | PE Ratio | |||
| — | — | — | — | — | — | — | — | — | — | PS Ratio | |||
| — | — | — | — | — | — | — | — | — | — | PB Ratio | |||
| — | — | — | — | — | — | — | — | — | — | EV/Sales | |||
| — | — | — | — | — | — | — | — | — | — | EV/FCF | |||
| — | — | — | — | — | — | — | — | — | 0 |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | — | — | — | — | Capex | |||
| — | — | — | — | — | — | — | — | — | 0 |
FCF
|
|||
| — | — | — | — | — | — | — | — | — | 3 |
Working Cap'
|
|||
| — | — | — | — | — | — | — | — | — | — | Total Debt | |||
| — | — | — | — | — | — | — | — | — | (3) |
Net Debt
|
|||
| — | — | — | — | — | — | — | — | — | (7) |
Sh' Equity
|
|||
| — | — | — | — | — | — | — | — | — | 0.00% |
ROA
|
|||
| — | — | — | — | — | — | — | — | — | 0.00% |
ROIC
|
|||
| — | — | — | — | — | — | — | — | — | 0.00% |
ROE
|
|||
predictions in italic, sparklines do not include predictions
Talon Capital Corp. peers in Shell Companies
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| WARR Warrior Technologies Acquisition Company | $345.3M | 4.7× | Compare |
| SBXE SilverBox Corp V | $350.4M | — | Compare |
| OYSE Oyster Enterprises II Acquisition Corp | $352.5M | — | Compare |
| BDCI BTC Development Corp | $352.9M | 35.5× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| CCII Cohen Circle Acquisition Corp. II | $357.3M | — | Compare |
| KCHV Kochav Defense Acquisition Corp. | $358.0M | — | Compare |
| BLUW Blue Water Acquisition Corp. III | $335.0M | — | Compare |
| XRPN Armada Acquisition Corp. II | $334.9M | — | Compare |
Talon Capital Corp. (TLNC) key facts
- Talon Capital Corp. (TLNC) is a Shell Companies company in the Financial sector, listed on Nasdaq.
- Net income was $2.6 million, or $0.33 per share (basic), a net margin of 0.00%.
- As of September 25, 2026, TLNC traded at $10.24, a market capitalization of $347.4 million.
- Return on equity was 0.00% and debt-to-equity 0.00.
Talon Capital Corp. (TLNC) Latest News
12 Jan
Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
Oricell Therapeutics has successfully closed the initial tranche of its Series C financing, raising US$70 million. This funding aims to accelerate the global development of its CAR-T therapies targeting solid tumors, enhancing the company's capabilities in the competitive oncology market. The financing supports product innovation in a growing sector, potentially influencing market positioning.
10 Sep
Talon Capital Corp. Announces Closing of $249 Million Initial Public Offering
Talon Capital Corp. closed its $249 million initial public offering. Closing of $249 million IPO delivers major capital infusion and public market access to Talon Capital Corp.